Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly Profit Beats Estimates on Lower Costs
Bloomberg
Wednesday, April 24, 2013 - 9:35am
tags:
earnings, Eli Lilly
Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy
Yahoo/AP
Wednesday, April 24, 2013 - 9:34am
tags:
Merck, lambrolizumab, FDA, MK-3475, melanoma
Novartis posts profit gain thanks to new drugs
Yahoo/AP
Wednesday, April 24, 2013 - 9:33am
tags:
earnings, Novartis
Boehringer anti-clotting pill gains blockbuster status
Reuters
Wednesday, April 24, 2013 - 8:47am
tags:
anticoagulants, Boehringer Ingelheim, Pradaxa
Elan sees sales of prized Tysabri drug rise sharply
Reuters
Wednesday, April 24, 2013 - 8:46am
tags:
Elan, Royalty Pharma, M&A, Tysabri
US Sues Novartis Over Alleged Fraudulent Kickbacks
CNBC/Reuters
Wednesday, April 24, 2013 - 8:44am
tags:
Novartis, kickbacks, Myfortic
Melanoma: Battle Of 3 Cancer Vaccines
Seeking Alpha
Tuesday, April 23, 2013 - 3:31pm
tags:
melanoma, vaccines, Amgen, Celldex, Oncothyreon, OncoSec, Vical
Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation
Yahoo/Minyanville
Tuesday, April 23, 2013 - 3:30pm
tags:
Medivation, Aragon, ARN-509, prostate cancer
3 Giant Drug Earnings Wed.: Glaxo, Lilly, Novartis
Investors.com
Tuesday, April 23, 2013 - 3:27pm
tags:
earnings, Novartis, Eli Lilly, GSK
Astrazeneca Earnings Preview: Can This Streak Continue?
Wall St. Cheat Sheet
Tuesday, April 23, 2013 - 3:27pm
tags:
earnings, AstraZeneca
Many Biotechs Fail To Embrace Reimbursement Issues
Pharmalot
Tuesday, April 23, 2013 - 11:36am
tags:
biotech, reimbursement
5 Top Biotechs With Bolting Stocks, Earnings On Tap
Investors.com
Tuesday, April 23, 2013 - 11:34am
tags:
earnings, Medicines Company, Celgene, Gilead, Amgen, Biogen Idec
Illumina Jumps Most in 15 Months on First-Quarter Profit
Bloomberg
Tuesday, April 23, 2013 - 11:31am
tags:
earnings, Illumina
FDA Scolds Teva For An Unbalanced And Overblown Handout
Pharmalot
Tuesday, April 23, 2013 - 11:23am
tags:
FDA, Teva, clozapine
Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race
TheStreet.com
Tuesday, April 23, 2013 - 11:21am
tags:
Gilead, Bristol-Myers Squibb, hepatitis C, sofosbuvir, daclatasvir, asunaprevir, BMS-791325
Gilead announces results from Phase 3 trial evaluating sofosbuvir
Yahoo/Fly on the Wall
Tuesday, April 23, 2013 - 11:06am
tags:
Gilead, hepatitis C, sofosbuvir
Biotechnology Draws Record Profit as Research Money Slows
Bloomberg
Tuesday, April 23, 2013 - 11:02am
tags:
biotech, R&D
Celsion's Shameless Spin Job
TheStreet.com
Tuesday, April 23, 2013 - 10:51am
tags:
Celsion, ThermoDox
Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402
Yahoo
Tuesday, April 23, 2013 - 10:50am
tags:
FDA, orphan drugs, Xenon, XEN402, erythromelalgia
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Bloomberg
Tuesday, April 23, 2013 - 10:49am
tags:
Sucampo, Amitiza, opioid-induced constipation

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.